SC 13G Filing

Company

BIOCRYST PHARMACEUTICALS INC

Filed

August 26, 2016

Accession Number

0001493152-16-012897

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →